Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:CUSIP |
45257F107
|
| gptkbp:focus |
gptkb:immunotherapy
infectious diseases oncology |
| gptkbp:foundedYear |
2014
|
| gptkbp:hasCompany |
gptkb:ImmunityBio,_Inc.
|
| gptkbp:headquartersLocation |
gptkb:Culver_City,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:ISIN |
US45257F1075
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:IBRX
|
| gptkbp:website |
https://immunitybio.com/
|
| gptkbp:bfsParent |
gptkb:NantCell
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ: IBRX
|